Simonis, Fabienne D.
Barbas, Carmen S. V.
Artigas-Raventós, Antonio
Canet, Jaume
Determann, Rogier M.
Anstey, James
Hedenstierna, Goran
Hemmes, Sabrine N. T.
Hermans, Greet
Hiesmayr, Michael
Hollmann, Markus W.
Jaber, Samir
Martin-Loeches, Ignacio
Mills, Gary H.
Pearse, Rupert M.
Putensen, Christian
Schmid, Werner
Severgnini, Paolo
Smith, Roger
Treschan, Tanja A.
Tschernko, Edda M.
Vidal Melo, Marcos F.
Wrigge, Hermann
de Abreu, Marcelo Gama
Pelosi, Paolo
Schultz, Marcus J.
Neto, Ary Serpa
Neto, Ary Serpa
Barbas, Carmen S. V.
Artigas-Raventós, Antonio
Canet, Jaume
Determann, Rogier M.
Dixon, Barry
Hedenstierna, Goran
Hemmes, Sabrine N. T.
Hermans, Greet
Hiesmayr, Michael
Hollmann, Markus W.
Jaber, Samir
Martin-Loeches, Ignacio
Mills, Gary H.
Pearse, Rupert M.
Putensen, Christian
Schmid, Werner
Severgnini, Paolo
Smith, Roger
Treschan, Tanja A.
Tschernko, Edda M.
Vidal Melo, Marcos F.
Wrigge, Hermann
de Abreu, Marcelo Gama
Pelosi, Paolo
Schultz, Marcus J.
Simonis, Fabienne D.
,
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Potentially modifiable respiratory variables contributing to outcome in ICU patients without ARDS: a secondary analysis of PRoVENT
https://doi.org/10.1186/s13613-018-0385-7
Article History
Received: 30 October 2017
Accepted: 12 March 2018
First Online: 21 March 2018